3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
4
Triple Negative Breast Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Pathologic Complete Response
1
Neutropenia
1
Neoplasms
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Limited Stage Small Cell Lung Cancer
1
Hemangiosarcoma
1
Carcinoma, Transitional Cell
1
Interventions
pembrolizumab
34
Cisplatin
29
Paclitaxel
15
Brachytherapy
15
Radiotherapy
14
Carboplatin
14
Bevacizumab
14
Blood Specimen Collection
13
Specimen Handling
12
Magnetic Resonance Spectroscopy
11
Colposcopy
11
Nivolumab
10
Drug Therapy
10
atezolizumab
8
Human Papillomavirus DNA Tests
8
Gemcitabine
8
lenvatinib
7
Radiation
6
Platinum
6
Biopsy
6
toripalimab
5
cemiplimab
5
Surveys and Questionnaires
5
Standard of Care
5
Radiotherapy, Intensity-Modulated
5
Practice Guidelines as Topic
5
Patient Navigation
5
Fulvestrant
5
Fluorodeoxyglucose F18
5
zimberelimab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
trilaciclib
×
1 year
×
Clear all
No trials found.